Anti-CD20 monoclonal antibody (rituximab) for the treatment of recurrent idiopathic membranous nephropathy in a renal transplant patient.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/CBA5CCA2.svg?ark=w1%2F20260515%2FCBA5CCA2)](https://nobleid.org/work/w1/20260515/CBA5CCA2)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors